101
Views
8
CrossRef citations to date
0
Altmetric
Original

Inhibition of ozone-induced SP-A oxidation by plant polyphenols

, , , , , , , , , , , & show all
Pages 357-366 | Received 14 Jul 2006, Published online: 07 Jul 2009

References

  • Floros J, Phelps DS. Pulmonary surfactant. Anesthesia: biologic foundations, TL Yaksh, C Lynch, III, WM Zapol, M Maze, JF Biebuyck, LJ Saidman. Lippincott-Raven, Philadelphia 1998; 1259–1279
  • Phelps DS, Taeusch HW, Jr, Benson B, Hawgood S. An electrophoretic and immunochemical characterization of human surfactant-associated proteins. Biochim Biophys Acta 1984; 791: 226–238
  • Ochs M, Johnen G, Muller KM, Wahlers T, Hawgood S, Richter J, Brasch F. Intracellular and intraalveolar localization of surfactant protein A (SP-A) in the parenchymal region of the human lung. Am J Respir Cell Mol Biol 2002; 26(1)91–98
  • Phelps DS, Floros J. Localization of surfactant protein synthesis in human lung by in situ hybridization. Am Rev Respir Dis 1988; 137(4)939–942
  • Phelps DS, Floros J. Localization of pulmonary surfactant proteins using immunohistochemistry and tissue in situ hybridization. Exp Lung Res 1991; 17(6)985–995
  • Floros J, Phelps DS. Pulmonary surfactant protein A: Structure, expression and its role in innate host defense. Surfactant. Update intensive care medicine, G Nakos, M Lekka. University of Ioannina, Ioannina 2002; 6: 87–102
  • Crouch E, Wright JR. Surfactant proteins A and D and pulmonary host defense. Annu Rev Physiol 2001; 63: 521–554
  • Ding J, Umstead TM, Floros J, Phelps DS. Factors affecting SP-A-mediated phagocytosis in human monocytic cell lines. Respir Med 2004; 98(7)637–650
  • Jenkin ME, Clemitshaw KC. Ozone and other secondary photochemical pollutants: Chemical processes governing their formation in the planetary boundary layer. Atmosph Environ 2000; 34: 2499–2527
  • US Environmental Protection Agency. National ambient air quality standards for ozone, Final Rule. Federal Register 1997; 62: 138
  • Putman E, van Golde LM, Haagsman HP. Toxic oxidant species and their impact on the pulmonary surfactant system. Lung 1997; 175(2)75–103
  • Aris RM, Christian D, Hearne PQ, Kerr K, Finkbeiner WE, Balmes JR. Ozone-induced airway inflammation in human subjects as determined by airway lavage and biopsy. Am Rev Respir Dis 1993; 148(5)1363–1372
  • Halliwell B, Cross CE. Oxygen derived species: Their relation to human disease and environmental stress. Environ Health Perspect 1994; 102: 5–12
  • Uppu RM, Cuento R, Squadrito GL, Pryor WA. What does ozone react with at the air/lung interface? Model studies using human red blood cell membranes. Arch Biochem Biophys 1995; 319: 257–266
  • Oosting RS, Van Iwaarden JF, Van Bree L, Verhoef J, Van Golde LM, Haagsman HP. Exposure of surfactant protein A to ozone in vitro and in vivo impairs its interactions with alveolar cells. Am J Physiol 1992; 262: L63–L68
  • Wang G, Umstead TM, Phelps DS, Al-Mondhiry H, Floros J. The effect of ozone exposure on the ability of human surfactant protein A variants to stimulate cytokine production. Environ Health Perspect 2002; 110: 79–84
  • Janic B, Umstead TM, Phelps DS, Floros J. An in vitro cell model system for the study of the effects of ozone and other gaseous agents on phagocytic cells. J Immunol Methods 2003; 272: 125–134
  • Wang G, Bates-Kenney SR, Tao JQ, Phelps DS, Floros J. Differences in biochemical properties and in biological function between human SP-A1 and SP-A2 variants, and the impact of ozone-induced oxidation. Biochemistry 2004; 43(14)4227–4239
  • Huang W, Wang G, Phelps DS, Al-Mondhiry H, Floros J. Human SP-A genetic variants and bleomycin-induced cytokine production by THP-1 cells: Effect of ozone-induced SP-A oxidation. Am J Physiol Lung Cell Mol Physiol 2004; 286(3)L546–L553
  • Starosta V, Griese M. Protein oxidation by chronic pulmonary diseases in children. Pediatr Pulmonol 2006; 41: 67–73
  • Starosta V, Rietschel E, Paul K, Baumann U, Griese M. Oxidative changes of bronchoalveolar proteins in cystic fibrosis. Chest 2006; 129: 431–437
  • Samet JM, Hatch GE, Horstman D, Steck-Scott S, Arab L, Bromberg PA, Levine M, McDonnell WF, Devlin RB. Effect of antioxidant supplementation on ozone-induced lung injury in human subjects. Am J Respir Crit Care Med 2001; 164(5)819–825
  • Steck-Scott S, Arab L, Craft NE, Samet JM. Plasma and lung macrophage responsiveness to carotenoid supplementation and ozone exposure in humans. Eur J Clin Nutr 2004; 58(12)1571–1579
  • Rice-Evans CA, Miller NJ, Paganga G. Structure-antioxidant activity relationships of flavonoids and phenolic acids. Free Radical Biol Med 1996; 20: 933–956
  • Nepka C, Sivridis E, Antonoglou O, Kortsaris A, Georgellis A, Taitzoglou I, Hytiroglou P, Papadimitriou C, Zintzaras I, Kouretas D. Chemopreventive activity of very low dose dietary tannic acid administration in hepatoma bearing C3H male mice. Cancer Lett 1999; 141(1/2)57–62
  • Yang CS, Landau JM, Huang MT, Newmark HL. Inhibition of carcinogenesis by dietary polyphenolic compounds. Annu Rev Nutr 2001; 21: 381–406
  • Curin Y, Andriantsitohaina R. Polyphenols as potential therapeutical agents against cardiovascular diseases. Pharmacol Rep 2005; 57: S97–S107
  • Lau FC, Shukitt-Hale B, Joseph JA. The beneficial effects of fruit polyphenols on brain aging. Neurobiol Aging 2005; 26: S128–S132
  • Riedl KM, Hagerman AE. Tannin-protein complexes as radical scavengers and radical sinks. J Agric Food Chem 2001; 49(10)4917–4923
  • Lambert JD, Yang CS. Mechanisms of cancer prevention by tea constituents. J Nutr 2003; 133(10)S3262–S3267
  • Stagos D, Kazantzoglou G, Magiatis P, Mitaku S, Anagnostopoulos K, Kouretas D. Effects of plant phenolics and grape extracts from Greek varieties of Vitis vinifera on mitomycin C and topoisomerase I-induced nicking of DNA. Int J Mol Med 2005; 15: 1013–1022
  • Haagsman HP, Hawgood S, Sargeant T, Buckley D, White RT, Drickamer K, Benson BJ. The major lung surfactant protein, SP 28-36, is a calcium-dependent, carbohydrate-binding protein. J Biol Chem 1987; 262: 13877–13880
  • Levine RL, Williams JA, Stadtman ER, Shacter E. Carbonyl assays for determination of oxidatively modified proteins. Methods Enzymol 1994; 233: 346–357
  • Umstead TM, Phelps DS, Wang G, Floros J, Tarkington BK. In vitro exposure of proteins to ozone. Toxic Mech Methods 2002; 12: 1–16
  • Janic B, Umstead MT, Phelps SD, Floros J. Modulatory effects of ozone on THP-1 cells in response to SP-A stimulation. Am J Physiol Lung Cell Mol Physiol 2005; 288: L317–L325
  • Kelly FJ, Mudway IS. Protein oxidation at the air-lung interface. Amino Acids 2003; 25(3/4)375–396
  • Pryor WA. Mechanisms of radical formation from reactions of ozone with target molecules in the lung. Free Radic Biol Med 1994; 17(5)451–465
  • Schunemann HJ, McCann S, Grant BJ, Trevisan M, Muti P, Freudenheim JL. Lung function in relation to intake of carotenoids and other antioxidant vitamins in a population-based study. Am J Epidemiol 2002; 155(5)463–471
  • Chung FL, Schwartz J, Herzog CR, Yang YM. Tea and cancer prevention: Studies in animals and humans. Proceedings of the third international scientific symposium on tea and human health. Role of flavonoids in the diet. 2002; 3268S–3274S
  • Paola R, Mazzon E, Muia C, Genovese T, Menegazzi M, Zaffini R, Suzuki H, Cuzzocrea S. Green tea polyphenol extract attenuates lung injury in experimental model of carrageenan-induced pleurisy in mice. Respir Res 2005; 6(1)66–78
  • Misra A, Chattopadhyay R, Banerjee S, Chattopadhyay DJ, Chatterjee IB. Black tea prevents cigarette smoke-induced oxidative damage of proteins in guinea pigs. Nutr Inter Tox 2003; 2622–2628
  • Hermans C, Bernard A. Lung epithelium-specific proteins: Characteristics and potential applications as markers. Am J Respir Crit Care Med 1999; 159: 646–678
  • Griese M. Pulmonary surfactant in health and human lung diseases: State of the art. Eur Respir J 1999; 131455–131476
  • Mustapha MG. Biochemical basis of ozone toxicity. Free Radic Biol Med 1990; 9: 245–265
  • Kroon PA, Clifford MN, Crozier A, Day AJ, Donovan JL, Manach C, Williamson G. How should we assess the effects of exposure to dietary polyphenols in vitro?. Am J Clin Nutr 2004; 80: 15–21
  • Manach C, Williamson G, Morand C, Scalbert A, Remesy C. Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am J Clin Nutr 2005; 81: 230S–242S
  • Manach C, Donovan JL. Pharmacokinetics and metabolism of dietary flavonoids in humans. Free Radic Res 2004; 38: 771–785
  • Stadtman ER, Levine RL. Protein oxidation. Ann NY Acad Sci 2000; 899: 191–208
  • Fauconneau B, Waffo-Teguo P, Huguet F, Barrier L, Decendit A, Merillon JM. Comparative study of radical scavenger and antioxidant properties of phenolic compounds from Vitis vinifera cell cultures using in vitro tests. Life Sci 1997; 61: 2103–2110
  • Heim KE, Tagliafero AR, Bobilya DJ. Flavonoid antioxidants: Chemistry, metabolism and structure-activity relationships. J Nutr Bioch 2002; 13: 572–584
  • Sroka Z, Cisowski W. Hydrogen peroxide scavenging, antioxidant and anti-radical activity of some phenolic acids. Food Chem Toxicol 2003; 41: 753–758
  • Levites Y, Amit T, Youdim BHM, Mandel S. Involvement of protein kinase C activation and cell survival/cell cycle genes in green tea polyphenol ( − )-epigallocatechin 3-gallate neuroprotective action. J Biol Chem 2002; 277(34)30574–30580
  • Levites Y, Youdim BHM, Maor G, Mandel S. Attenuation of 6-hydroxydopamine (6-OHDA)-induced nuclear factor-kappaB (NF-κB) activation and cell death by tea extracts in neuronal cultures. Biochem Pharm 2002; 63: 21–29
  • Halliwell B. Vitamin C, antioxidant or pro-oxidant in vivo?. Free Radic Res 1996; 25: 439–454
  • Gassen M, Gross A, Youdim MB. Apomorphine enantiomers protect cultured pheochromocytoma (PC12) cells from oxidative stress induced by H2O2, and 6-hydroxydopamine. Movement Dis 1998; 13: 242–248
  • Asquith TN, Butler LG. Interactions of condensed tannins with selected proteins. Phytochemistry 1986; 25: 1591–1593
  • Hagerman AE, Butler LG. The specificity of proanthocyanidin-protein interactions. J Biol Chem 1981; 256(9)4494–4497
  • Practical polyphenolics–from structures to molecular recognition and physiological action, E Haslam. Cambridge Univ Press, Cambridge 1999
  • Jobstl E, O'Connell J, Fairclough JP, Williamson MP. Molecular model for astringency produced by polyphenol/protein interactions. Biomacromolecules 2004; 5(3)942–949
  • Richard T, Vitrac X, Merillon JM, Monti JP. Role of peptide primary sequence in polyphenol-protein recognition: An example with neurotensin. Biochim Biophys Acta 2005; 1726(3)238–243
  • Chen Y, Hagerman AE. Quantitative examination of oxidized polyphenol-protein complexes. J Agric Food Chem 2004; 52(20)6061–6067
  • Alvarez ML, Debattista NB, Pappano NB. Synergism of flavonoids with bacteriostatic action against Staphylococcus aureus ATCC 25 923 and Escherichia coli ATCC 25 922. Biocell 2006; 30: 39–42
  • Orsolic N, Kosalec I, Basic I. Synergistic antitumor effect of polyphenolic components of water soluble derivative of propolis against Ehrlich ascites tumour. Biol Pharm Bull 2005; 28: 694–700
  • Liu RH. Potential synergy of phytochemicals in cancer prevention: Mechanism of action. J Nutr 2004; 134: 3479S–3485S

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.